Provided by Tiger Trade Technology Pte. Ltd.

Enveric Biosciences

1.88
+0.02001.08%
Post-market: 1.80-0.0799-4.25%19:58 EDT
Volume:51.38K
Turnover:98.14K
Market Cap:2.61M
PE:-0.02
High:1.97
Open:1.85
Low:1.84
Close:1.86
52wk High:19.20
52wk Low:1.82
Shares:1.39M
Float Shares:1.28M
Volume Ratio:2.21
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-93.5500
EPS(LYR):-228.4745
ROE:-262.78%
ROA:-133.22%
PB:0.76
PE(LYR):-0.01

Loading ...

Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY

Benzinga
·
13 hours ago

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025

Dow Jones
·
13 hours ago

Enveric Biosciences Inc: Q4 Net Loss per Share $6.12

THOMSON REUTERS
·
13 hours ago

Enveric Biosciences FY2025 net loss climbs 25% to $4.0 million; cash-on-hand falls to $4.7 million

Reuters
·
13 hours ago

BRIEF-Enveric Biosciences Announces Registration Of Five Trademarks

Reuters
·
Mar 18

Enveric Biosciences Announces Registration of Five Trademarks

THOMSON REUTERS
·
Mar 18

Enveric Biosciences Inc: No Remaining Challenges Currently Pending Against Enveric's Patent

THOMSON REUTERS
·
Feb 25

Enveric Biosciences Inc - Announces Withdrawal of Pgr Petition Filed by Gilgamesh Pharmaceuticals Against Its Patent

THOMSON REUTERS
·
Feb 25

Enveric Biosciences Wins Withdrawal of Patent Challenge

Reuters
·
Feb 25

Gilgamesh Withdraws Patent Fight Against Enveric After $1.2 Billion AbbVie Deal, CEO Says Key Drug Claims Now Uncontested

Benzinga_recent_news
·
Feb 25

Enveric Biosciences reports new EB-003 5-HT2A receptor BRET assay data

Reuters
·
Feb 19

Enveric Advances Lead Drug With New Findings On Key Brain Receptor Signals

Benzinga_recent_news
·
Feb 19

Enveric Biosciences Expands At-The-Market Equity Offering Capacity

TIPRANKS
·
Feb 07

Enveric Biosciences kündigt Aktienplatzierung im Volumen von 1,35 Millionen US-Dollar an

Reuters
·
Feb 07

Enveric Biosciences: May Offer & Sell Co's Common Stock Having an Aggregate Offering Price of up to $1.3 Mln From Time to Time Through Wainwright

THOMSON REUTERS
·
Feb 07

Enveric Biosciences Licenses RCANN Trademark Portfolio to TOTEC Pharma

Reuters
·
Jan 29

Enveric Biosciences Expands Collaboration With Totec Pharma Through Trademark License and Option

THOMSON REUTERS
·
Jan 29

Enveric Biosciences Raises Capital Through Equity Offering

TIPRANKS
·
Jan 29

Enveric Biosciences Issues Warrants to Purchase 657,604 Shares in Direct Offering

Reuters
·
Jan 29

Enveric Biosciences Shares Drop Premarket After $1.5M Equity Raising Prices

Dow Jones
·
Jan 28